Table 3 Univariate analysis of risk factors for the survival of ACLF patients
Related factors | Survivor (n = 76) (Mean ± SD) | Non-survivor (n = 55) (Mean ± SD) | t or χ 2 value | P value |
|---|---|---|---|---|
Male (%) | 64 (84.21) | 47 (85.45) | 0.04 | 0.85 |
HBeAg positive (%) | 19 (25.00) | 18 (32.73) | 0.94 | 0.33 |
Treatment without NAs (%) | 30 (39.47) | 40 (72.73) | 14.18 | <0.001 |
Age (yr) | 39.49 ± 10.50 | 45.05 ± 9.96 | 3.06 | 0.003 |
HBV DNA log10 (copies/ml) | 5.52 ± 1.40 | 5.50 ± 1.60 | 0.08 | 0.94 |
TBIL (μmol/L) | 271.33 ± 111.05 | 265.23 ± 122.78 | 0.30 | 0.77 |
Albumin (g/L) | 34.67 ± 5.44 | 34.34 ± 4.77 | 0.37 | 0.71 |
ALT (U/L) | 912.92 ± 861.61 | 950.50 ± 744.03 | 0.26 | 0.80 |
PTA (%) | 33.81 ± 9.40 | 30.21 ± 10.50 | 2.05 | 0.042 |
Creatinine (μmol/L) | 66.66 ± 14.74 | 79.03 ± 57.78 | 1.55 | 0.13 |
MELD Score | 22.11 ± 2.84 | 25.24 ± 6.19 | 3.49 | 0.001 |